El Dr. Pedro Moliner Borja analiza los resultados del estudio publicado en AHA Scientific Sessions 2019.

1. DAPA-HF: QoL results Pedro Moliner Borja
Effect of Treatment on KCCQ in DAPA-HF
Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trail (DAPA-HF)

2. DAPA-HF: QoL results Pedro Moliner Borja

3. DAPA-HF: QoL results Pedro Moliner Borja

4. DAPA-HF: QoL results Pedro Moliner Borja

5. DAPA-HF: QoL results Pedro Moliner Borja

6. DAPA-HF: QoL results Pedro Moliner Borja

7. DAPA-HF: QoL results Pedro Moliner Borja

8. DAPA-HF: QoL results Pedro Moliner Borja

9. DAPA-HF: QoL results Pedro Moliner Borja

10. DAPA-HF: QoL results Pedro Moliner Borja

11. DAPA-HF: QoL results Pedro Moliner Borja

12. DAPA-HF: QoL results Pedro Moliner Borja

13. DAPA-HF: QoL results Pedro Moliner Borja

14. DAPA-HF: QoL results Pedro Moliner Borja